Vericel to Expand MACI Salesforce Again on Strong Demand

By Mike Evers

Vericel’s 3Q19 grow was attributable to continued strong demand for MACI, and the company expects to maintain double-digit growth in the years ahead.

Member-Only Content

SUBSCRIBE Login

Product Labels: PRP/Cell-Based/Osteoinductive Materials

Tags: Revenue Report